Kyntra Bio (KYNB) Enterprise Value (2014 - 2026)

Kyntra Bio has disclosed Enterprise Value across 13 years of filings, most recently posting -$39.3 million for Q2 2026.

• In Q2 2026, Enterprise Value fell 360.72% year-over-year to -$39.3 million; the TTM figure through Jun 2026 stood at -$39.3 million (down 360.72% YoY), while the FY2025 annual figure was -$32.0 million, up 3.8% from the prior year.
• Enterprise Value came in at -$39.3 million for Q2 2026 at Kyntra Bio, down from -$38.3 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $1.5 billion in Q1 2023 to a low of -$145.0 million in Q3 2023.
• Average Enterprise Value over 5 years is $229.1 million, with a median of -$32.6 million recorded in 2024.
• Year-over-year, Enterprise Value soared 129.22% in 2025 and sank 401.7% in 2026.
• Over 5 years, Enterprise Value stood at $1.1 billion in 2022, then plunged by 111.65% to -$126.6 million in 2023, then jumped by 73.75% to -$33.2 million in 2024, then grew by 3.8% to -$32.0 million in 2025, then fell by 22.85% to -$39.3 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$39.3 million in Q2 2026, -$38.3 million in Q1 2026, and -$32.0 million in Q4 2025.